Apalutamide
Drug timelines are a Plus or Pro feature.
38 regulatory and trial events tracked for Apalutamide, covering 2018-06-19 to 2026-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer [Phase 3]